Amylin Said to Attract Interest From Pfizer, AstraZeneca

Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker’s sale process, said people familiar with the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.